Terbinafine vs. Azole Antifungals: Key Differences in Indications
Terbinafine is specifically indicated for dermatophyte infections (particularly onychomycosis), while azoles have broader indications covering dermatophytes, Candida species, and other yeasts. 1
Spectrum of Activity
Terbinafine
- Primary indication: Onychomycosis (toenail/fingernail) caused by dermatophytes (tinea unguium) 1
- Fungicidal against dermatophytes, particularly Trichophyton rubrum and T. mentagrophytes 2
- Limited activity against Candida species (fungistatic at best, significantly inferior to azoles) 2
- Not effective for yeast infections or non-dermatophyte molds
Azoles (Itraconazole, Fluconazole)
- Broader spectrum: Effective against both dermatophytes AND Candida species 2
- Fungistatic mechanism (vs. terbinafine's fungicidal action) 2
- Useful for mixed infections involving yeasts
- Fluconazole has particular activity against Candida species 2
Clinical Efficacy Hierarchy
For dermatophyte onychomycosis specifically, terbinafine should be first-line treatment based on superior cure rates 2:
- Terbinafine achieves 55% complete cure vs. 26% with itraconazole at 72 weeks 2
- Long-term mycological cure: 46% (terbinafine) vs. 13% (itraconazole) at 5 years 2
- Relapse rates significantly lower: 23% (terbinafine) vs. 53% (itraconazole) 2
When to Choose Each Agent
Choose Terbinafine When:
- Confirmed dermatophyte infection (especially T. rubrum, T. mentagrophytes)
- Onychomycosis is the primary diagnosis
- Patient has minimal drug-drug interaction concerns (terbinafine only affects CYP2D6) 2
- Shorter treatment duration desired (6 weeks for fingernails, 12-16 weeks for toenails) 2
Choose Azoles When:
- Candida or mixed yeast/dermatophyte infections suspected
- Non-dermatophyte mold infections
- Patient cannot tolerate terbinafine
- Significant CYP2D6 drug interactions are not a concern (azoles have MORE drug interactions than terbinafine) 2
- Pulse therapy preferred for compliance (itraconazole can be dosed 1 week per month) 2
Critical Pitfalls
Common mistake: Using azoles as first-line for proven dermatophyte onychomycosis—this results in lower cure rates and higher relapse 2. Always confirm the organism type before selecting therapy; if dermatophyte is confirmed, terbinafine is superior.
Warning about resistance: Azoles are fungistatic and permit mutations in ergosterol biosynthesis enzymes, leading to resistance development in dermatophytes 3. Terbinafine's fungicidal mechanism and toxic squalene accumulation make resistance less likely.